Post Test - Begin with the Lid in Mind: Demodex Blepharitis and MGD*This post test is NOT required unless your state board requires one for CE credit. Please check with your individual state board. Name * First Name Last Name Email License State and Number Lotilaner, the active drug of a new FDA approved therapeutic, was extensively used in veterinary medicine to treat dog’s with mange. What does it target in humans? Staphylococcal blepharitis Demodex blepharitis Seborrheic blepharitis Cicatricial blepharitis Which of the following is NOT a sign of MGD/Lid margin disease Anteriorly placed meibomian glands Telangiectasia Capped glands Scalloped eyelid margins Which of the following newly FDA approved therapeutics, essentially mimics the lipid layer creating a new monolayer that reduces evaporation for more than 4-6 hours? Reproxalap Perflurobutylpentane Perfluorohexylocatane Lotilaner What percentage of glaucoma patients taking topical prostaglandin drops have MGD? 10% 48% 72% 96% The vast majority of MGD is termed as non-obvious by Donald Korb, OD,(72-78%), so how might a clinician best determine if MGD is present? Express the meibomian glands Take SPEED questionnaire scores Look for collarettes Observe scurf or debris on the lashes Why is lotilaner 0.25% recommended treatment duration 6 weeks? The life cycle of the pathogen is 3 weeks + 3 weeks for the eggs and nits that hatch Because the bottle size allows for 6 weeks To prevent resistance Because it takes a full six weeks to see improvement in collarettes The best way to diagnose demodex blepharitis is to have the patient: State that itching is their primary symptom Have the patient look down while at the slit lamp and scan the eye lash margin Express the meibomian glands for paste-like expression Pluck lashes and observe demodex mites at the slit lamp In the ERSA study, what was lotilaner 0.25% shown to improve: Staphylococcal blepharitis MGD or meibomian gland function Seborrheic blepharitis Erythema A patient with morning symptoms is most likely to have: Blepharitis Epithelial basement membrane dystrophy (EBMD) Inadequate lid seal (ILS) Evaporative Dry Eye Disease (EDED) In the Titan study, what percentage of patients visiting an optometry or ophthalmology office had collarettes: 12% 36% 58% 85% Thank you submitting your responses. They have been recorded. Please email us if you need a copy for your state board.
